Hello and welcome to the details of Egypt receives second shipment of Chinese coronavirus vaccine and now with the details
Subscribe to our Telegram channel for the latest updates on news you need to know.
CAIRO, Feb 23 ― Egypt received 300,000 doses of a coronavirus vaccine developed by China National Pharmaceutical Group (Sinopharm) in the early hours of today, the health ministry said in a statement.
The new batch from China was the second shipment of the Sinopharm vaccine to Egypt. The country received its first 50,000-dose shipment in December.
The North African country also got 50,000 doses of a vaccine developed by AstraZeneca earlier in February as part of its programme to vaccinate health workers.
Egypt began vaccinating frontline medical staff against Covid-19 on January 24 using the Chinese vaccine.
Egypt will open an online registration process next week for other groups eligible for vaccination, such as the elderly and patients with chronic diseases, Mostafa Ghoneima, a health minister assistant, told Reuters.
Vaccination of these groups will start with the arrival of more shipments of vaccines, he said at the Cairo airport upon the arrival of the latest shipment of Sinopharm vaccines.
As of yesterday, Egypt had confirmed 178,774 coronavirus cases, including 10,404 deaths, since the start of the pandemic more than 10 months ago.
However, health officials say the real number is likely far higher because of the relatively low rate of coronavirus testing and the exclusion of private test results. ― Reuters
These were the details of the news Egypt receives second shipment of Chinese coronavirus vaccine for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.